Mini-Mental State Examination score and B-type natriuretic peptide as predictors of cardiovascular and total mortality in an elderly general population

Annals of Medicine

Volumn 43, Issue 8, 2011, Pages 650-659

  Kerola, Tuomas ^a   Hiltunen, Matti ^b,c   Kettunen, Raimo ^a   Hartikainen, Sirpa ^d,e   Sulkava, Raimo ^d   Vuolteenaho, Olli ^f   Nieminen, Tuomo ^a,g,h  

^a PÄIJÄT HÄME CENTRAL HOSPITAL   (Finland)

^b HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^c KANTA HÄME CENTRAL HOSPITAL   (Finland)

^d UNIVERSITY OF EASTERN FINLAND   (Finland)

^e Leppavirta Health Centre   (Finland)

^f UNIVERSITY OF OULU   (Finland)

^g TAMPERE UNIVERSITY OF TECHNOLOGY   (Finland)

^h BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

Author keywords

Cardiovascular mortality; Cognition; Elderly; MMSE; Natriuretic peptides; Risk marker

Indexed keywords

BRAIN NATRIURETIC PEPTIDE;

AGED; ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; COHORT ANALYSIS; DISEASE SEVERITY; FEMALE; FINLAND; HUMAN; MAJOR CLINICAL STUDY; MALE; MILD COGNITIVE IMPAIRMENT; MINI MENTAL STATE EXAMINATION; MORTALITY; PRIORITY JOURNAL; PROSPECTIVE STUDY; SCREENING;

AGED; CARDIOVASCULAR DISEASES; COGNITION DISORDERS; DEMENTIA; FEMALE; FINLAND; GERIATRIC ASSESSMENT; HEART FAILURE; HUMANS; MALE; MILD COGNITIVE IMPAIRMENT; MORTALITY; MULTIVARIATE ANALYSIS; NATRIURETIC PEPTIDE, BRAIN; NEUROPSYCHOLOGICAL TESTS; PREDICTIVE VALUE OF TESTS; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES;

EID: 80555139089     PISSN: 07853890     EISSN: 13652060     Source Type: Journal    
DOI: 10.3109/07853890.2010.526137     Document Type: Article

References (33)

1. Schupf N, Costa R, Luchsinger J, Tang MX, Lee JH, Mayeux R. Relationship between plasma lipids and all-cause mortality in nondemented elderly. J Am Geriatr Soc. 2005;53:219-26. (Pubitemid 41632547)
2. Oates DJ, Berlowitz DR, Glickman ME, Silliman RA, Borzecki AM. Blood pressure and survival in the oldest old. J Am Geriatr Soc. 2007;55:383-8. (Pubitemid 46331813)
3. Takata Y, Ansai T, Soh I, Akifusa S, Sonoki K, Fujisawa K, et al. Association between body mass index and mortality in an 80-year-old population. J Am Geriatr Soc. 2007;55:913-7. (Pubitemid 47011030)
4. Wang TJ, Larson MG, Levy D, Benjamin EJ, Leip EP, Omland T, et al. Plasma natriuretic peptide levels and the risk of cardiovascular events and death. N Engl J Med. 2004; 350:655-63. (Pubitemid 38364624)
5. Kistorp C, Raymond I, Pedersen F, Gustafsson F, Faber J, Hildebrandt P. N-terminal pro-brain natriuretic peptide, C-reactive protein, and urinary albumin levels as predictors of mortality and cardiovascular events in older adults. JAMA. 2005;293:1609-16. (Pubitemid 40471791)
6. Wallen T, Landahl S, Hedner T, Nakao K, Saito Y. Brain natriuretic peptide predicts mortality in the elderly. Heart. 1997;77:264-7. (Pubitemid 27122781)
7. Kelman HR, Thomas C, Kennedy GJ, Cheng J. Cognitive impairment and mortality in older community residents. Am J Public Health. 1994;84:1255-60. (Pubitemid 24250693)
8. Larson EB, Shadlen MF, Wang L, McCormick WC, Bowen JD, Teri L, et al. Survival after initial diagnosis of Alzheimer disease. Ann Intern Med. 2004;140:501-9.
9. Stump TE, Callahan CM, Hendrie HC. Cognitive impairment and mortality in older primary care patients. J Am Geriatr Soc. 2001;49:934-40. (Pubitemid 32743629)
10. Nguyen HT, Black SA, Ray LA, Espino DV, Markides KS. Cognitive impairment and mortality in older Mexican Americans. J Am Geriatr Soc. 2003;51:178-83. (Pubitemid 36205845)
11. Fried LP, Kronmal RA, Newman AB, Bild DE, Mittelmark MB, Polak JF, et al. Risk factors for 5-year mortality in older adults: the Cardiovascular Health Study. JAMA. 1998; 279:585-92. (Pubitemid 28110204)
12. Strandberg TE, Pitkala KH, Tilvis RS. Predictors of mortality in home-dwelling patients with cardiovascular disease aged 75 and older. J Am Geriatr Soc. 2009;57:279-84.
13. Ganguli M, Dodge HH, Shen C, Pandav RS, DeKosky ST. Alzheimer disease and mortality: a 15-year epidemiological study. Arch Neurol. 2005;62:779-84. (Pubitemid 40656094)
14. Jagger C, Andersen K, Breteler MM, Copeland JR, Helmer C, Baldereschi M, et al. Prognosis with dementia in Europe: A collaborative study of population-based cohorts. Neurologic Diseases in the Elderly Research Group. Neurology. 2000;54(11 Suppl 5):16-20.
15. K loppenborg RP, van den Berg E, Kappelle LJ, Biessels GJ. Diabetes and other vascular risk factors for dementia: which factor matters most? A systematic review. Eur J Pharmacol. 2008;585:97-108.
16. Fitzpatrick AL, Kuller LH, Lopez OL, Diehr P, O'Meara ES, Longstreth WT Jr, et al. Midlife and late-life obesity and the risk of dementia: cardiovascular health study. Arch Neurol. 2009;66:336-42.
17. Cacciatore F, Abete P, Ferrara N, Calabrese C, Napoli C, Maggi S, et al. Congestive heart failure and cognitive impairment in an older population. Osservatorio Geriatrico Campano Study Group. J Am Geriatr Soc. 1998;46:1343-8. (Pubitemid 28511873)
18. Zuccal àG, Pedone C, Cesari M, Onder G, Pahor M, Marzetti E, et al. The effects of cognitive impairment on mortality among hospitalized patients with heart failure. Am J Med. 2003;115:97-103. (Pubitemid 37288836)
19. Feola M, Rosso GL, Peano M, Agostini M, Aspromonte N, Carena G, et al. Correlation between cognitive impairment and prognostic parameters in patients with congestive heart failure. Arch Med Res. 2007;38:234-9. (Pubitemid 46080551)
20. Kerola T, Nieminen T, Sulkava R, Hartikainen S, Vuolteenaho O, Kettunen R. B-type natriuretic peptide as a predictor of declining cognitive function and dementia-a cohort study of an elderly general population with a 5-year followup. Ann Med. 2010;42:207-15.
21. McKeith IG, Galasko D, Kosaka K, Perry EK, Dickson DW, Hansen LA, et al. Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): report of the consortium on DLB international workshop. Neurology. 1996;47:1113-24. (Pubitemid 26374873)
22. Zung WW. A self-rating depression scale. Arch Gen Psychiatry. 1965;12:63-70.
23. Ala-Kopsala M, Magga J, Peuhkurinen K, Leipä l ä J, Ruskoaho H, Lepp ä luoto J, et al. Molecular heterogeneity has a major impact on the measurement of circulating N-terminal fragments of A-and B-type natriuretic peptides. Clin Chem. 2004;50:1576-88. (Pubitemid 39121226)
24. Greenland S. Dose-response and trend analysis in epidemiology: alternatives to categorical analysis. Epidemiology. 1995;6:356-65.
25. Bassuk SS, Wypij D, Berkman LF. Cognitive impairment and mortality in community-dwelling elderly. Am J Epidemiol. 2000;151:677-88.
26. Iadecola C, Davisson RL. Hypertension and cerebrovascular dysfunction. Cell Metab. 2008;7:476-84. (Pubitemid 351729202)
27. Buerger K, Ernst A, Ewers M, Uspenskaya O, Omerovic M, Morgenthaler NG, et al. Blood-based microcirculation markers in Alzheimer' s disease-diagnostic value of midregional pro-atrial natriuretic peptide/C-terminal endothelin-1 precursor fragment ratio. Biol Psychiatry. 2009;65: 979-84.
28. Vuolteenaho O, Ala-Kopsala M, Ruskoaho H. BNP as a biomarker in heart disease. Adv Clin Chem. 2005;40:1-36. (Pubitemid 43588719)
29. Redfield MM, Jacobsen SJ, Burnett JC Jr, Mahoney DW, Bailey KR, Rodeheffer RJ. Burden of systolic and diastolic ventricular dysfunction in the community: appreciating the scope of the heart failure epidemic. JAMA. 2003;289: 194-202. (Pubitemid 36068707)
30. Strandberg TE, Tilvis RS. C-reactive protein, cardiovascular risk factors, and mortality in a prospective study in the elderly. Arterioscler Thromb Vasc Biol. 2000;20: 1057-60. (Pubitemid 30207582)
31. Suwa M, Ito T. Correlation between cognitive impairment and left ventricular diastolic dysfunction in patients with cardiovascular diseases. Int J Cardiol. 2009;136:351-4.
32. Allender S, Peto V, Scarborough P, Rayner M. Coronary heart disease statistics. British Heart Foundation; London 2008.
33. Py ör äl ä K, Salonen JT, Valkonen T. Trends in coronary heart disease mortality and morbidity and related factors in Finland. Cardiology. 1985;72:35-51. (Pubitemid 15163598)